Multicenter Study Shows Reproducible Clinical and Operational Gains Following Expansion of IntelliSep Sepsis Test Across Health System

Cytovale® today announced new multicenter, real-world data demonstrating that clinical and operational improvements in sepsis care first observed at a high-volume emergency department (ED) in Baton ...
ascopubs.org

Study of JAK inhibition in stem-like prostate cancer (JASPER): A phase 1/2 multicenter study of ruxolitinib and enzalutamide in castration resistant prostate cancer undergoing ...

Bipolar androgen therapy (BAT) for nonmetastatic castration-resistant prostate (nmCRPC) cancer progressing on darolutamide: Working Out M0 BAT (WOMBAT; ANZUP 2201). This is an ASCO Meeting Abstract ...

Peer-Reviewed Study Shows IntelliSep Influences ED Physicians' Sepsis Diagnostic Decisions

A new peer-reviewed study published in JACEP Open found that providing emergency department (ED) physicians with IntelliSep(R) sepsis test results was associated with improved diagnostic accuracy and ...
EurekAlert!

Study illuminates benefits of red blood cell exchange in severe babesiosis

A new study led by investigators from Mass General Brigham and Yale School of Public Health reveals that red blood cell exchange transfusion (ET) may provide critical benefits for patients ...
Medycyna Praktyczna

Type 2 diabetes mellitus remission 10 years after metabolic and bariatric surgery: a multicenter retrospective study in Poland (BARI‑10‑POL)

Introduction: Type 2 diabetes mellitus (T2DM), a chronic metabolic disease, affects millions of people worldwide, causes numerous complications, (eg, cardiovascular dise ...
ascopubs.org

Prospective Multicenter Study Evaluating a Combined Circulating Tumor DNA and Circulating Tumor RNA Liquid Biopsy in Metastatic Non–Small Cell Lung Cancer (LIQUIK)

This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.